ASAkul Singhania

Akul Singhania

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akul Singhania has a total of 333 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature

    by Akul Singhania, Paige Dubelko, Rebecca Kuan, William D. Chronister, Kaylin Muskat, Jyotirmoy Das, Elizabeth J. Phillips, Simon A. Mallal, Grégory Seumois, Pandurangan Vijayanand, et al.


  • Open Access

    A metric for evaluating biological information in gene sets and its application to identify co-expressed gene clusters in PBMC

    by Jason Bennett, Mikhail Pomaznoy, Akul Singhania, Bjoern Peters

    Recent technological advances have made the gathering of comprehensive gene expression datasets a commodity. This has shifted the limiting step of transcriptomic studies from the accumulation of data to their analyses and interpretation. The main problem in analyzing transcriptomics data is that the number of independent samples is typically much lower (14,000). To address this, it would be desirable to reduce the gathered data’s dimensionality without losing information. Clustering genes into discrete modules is one of the most commonly used tools to accomplish this task. While there are multiple clustering approaches, there is a lack of informative metrics available to evaluate the resultant clusters’ biological quality. Here we present a metric that incorporates known ground truth gene sets to quantify gene clusters’ biological quality derived from standard clustering techniques. The GECO (Ground truth Evaluation of Clustering Outcomes) metric demonstrates that quantitative and repeatable scoring of gene clusters is not only possible but computationally lightweight and robust. Unlike current methods, it allows direct comparison between gene clusters generated by different clustering techniques. It also reveals that current cluster analysis techniques often underestimate the number of clusters that should be formed from a dataset, which leads to fewer clusters of lower quality. As a test case, we applied GECO combined with k-means clustering to derive an optimal set of co-expressed gene modules derived from PBMC, which we show to be superior to previously generated modules generated on whole-blood. Overall, GECO provides a rational metric to test and compare different clustering approaches to analyze high-dimensional transcriptomic data.


  • Open Access

    Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease

    by Julie G. Burel, Akul Singhania, Paige Dubelko, Julius Muller, Rachel Tanner, Eneida Parizotto, Martin Dedicoat, Thomas E. Fletcher, James Dunbar, Adam F. Cunningham, et al.


  • Top Cited Papers
    Open Access

    Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis

    by Olivier Tabone, Raman Verma, Akul Singhania, Probir Chakravarty, William J. Branchett, Christine M. Graham, Jo Lee, Tran Trang, Frederic Reynier, Philippe Leissner, et al.

    Blood transcriptomics have revealed major characteristics of the immune response in active TB, but the signature early after infection is unknown. In a unique clinically and temporally well-defined cohort of household contacts of active TB patients that progressed to TB, we define minimal changes in gene expression in incipient TB increasing in subclinical and clinical TB. While increasing with time, changes in gene expression were highest at 30 d before diagnosis, with heterogeneity in the response in household TB contacts and in a published cohort of TB progressors as they progressed to TB, at a bulk cohort level and in individual progressors. Blood signatures from patients before and during anti-TB treatment robustly monitored the treatment response distinguishing early and late responders. Blood transcriptomics thus reveal the evolution and resolution of the immune response in TB, which may help in clinical management of the disease.


  • Open Access

    Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma

    by Simon Couillard, James Melhorn, Akul Singhania, Daniel Horowitz, Ratko Djukanović, Christpher H Woelk, Timothy S C Hinks

    Background: Eotaxin-3 is an eosinophilic chemokine. We investigated how its expression in the bronchial epithelium correlates with other IL-13 signature genes in asthma. Methods: We performed a post-hoc analysis of data in patients with asthma and healthy controls (PMID#28933920). Asthma inflammatory phenotype was determined by the induced sputum differential: eosinophilic >3%, neutrophilic >61%. Bronchial epithelial gene expression was measured using RNA microarrays on endobronchial brushes. Eotaxin-3 gene expression was compared between phenotypes by one-way ANOVA corrected for 10 comparisons. Pearson correlations (pin vitro epithelial cell studies. Results: Data from 38 asthmatics and 18 controls were included. Eotaxin-3 gene expression was highest in eosinophilic asthma (Fig 1A). The correlation matrix (Fig 1B) shows strong associations between eotaxin-3 gene expression and IL-13-induced-genes in patients with asthma. The 3 most correlated genes were Serpin Family B Member 10 (SERPINB10: r=0.85), periostin (POSTN: r=0.79) and nitric oxide synthase 2 (NOS2: r=0.72). Correlations in controls were not significant (not shown). Conclusion: Eotaxin-3 gene expression is upregulated in the airway epithelium in eosinophilic asthma and highly correlates with IL-13 signature genes – including biomarker genes POSTN and NOS2.


  • Top Cited Papers

    Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis

    by Lúcia Moreira-Teixeira, Olivier Tabone, Christine M. Graham, Akul Singhania, Evangelos Stavropoulos, Paul S. Redford, Probir Chakravarty, Simon L. Priestnall, Alejandro Suarez-Bonnet, Eleanor Herbert, et al.

    Although mouse infection models have been extensively used to study the host response to Mycobacterium tuberculosis, their validity in revealing determinants of human tuberculosis (TB) resistance and disease progression has been heavily debated. Here, we show that the modular transcriptional signature in the blood of susceptible mice infected with a clinical isolate of M. tuberculosis resembles that of active human TB disease, with dominance of a type I interferon response and neutrophil activation and recruitment, together with a loss in B lymphocyte, natural killer and T cell effector responses. In addition, resistant but not susceptible strains of mice show increased lung B cell, natural killer and T cell effector responses in the lung upon infection. Notably, the blood signature of active disease shared by mice and humans is also evident in latent TB progressors before diagnosis, suggesting that these responses both predict and contribute to the pathogenesis of progressive M. tuberculosis infection.


  • Open Access

    Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases

    by Akul Singhania, Christine M. Graham, Leona Gabryšová, Lúcia Moreira-Teixeira, Evangelos Stavropoulos, Jonathan M. Pitt, Probir Chakravarty, Annika Warnatsch, William J. Branchett, Laura Conejero, et al.

    Understanding how immune challenges elicit different responses is critical for diagnosing and deciphering immune regulation. Using a modular strategy to interpret the complex transcriptional host response in mouse models of infection and inflammation, we show a breadth of immune responses in the lung. Lung immune signatures are dominated by either IFN-γ and IFN-inducible, IL-17-induced neutrophil- or allergy-associated gene expression. Type I IFN and IFN-γ-inducible, but not IL-17- or allergy-associated signatures, are preserved in the blood. While IL-17-associated genes identified in lung are detected in blood, the allergy signature is only detectable in blood CD4+effector cells. Type I IFN-inducible genes are abrogated in the absence of IFN-γ signaling and decrease in the absence of IFNAR signaling, both independently contributing to the regulation of granulocyte responses and pathology duringToxoplasma gondiiinfection. Our framework provides an ideal tool for comparative analyses of transcriptional signatures contributing to protection or pathogenesis in disease.


  • Open Access

    Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

    by Zala Jevnikar, Jörgen Östling, Elisabeth Ax, Jenny Calvén, Kristofer Thörn, Elisabeth Israelsson, Lisa Öberg, Akul Singhania, Laurie C.K. Lau, Susan J. Wilson, et al.


  • Open Access

    OnPLS-Based Multi-Block Data Integration: A Multivariate Approach to Interrogating Biological Interactions in Asthma

    by Stacey N. Reinke, Beatriz Galindo-Prieto, Tomas Skotare, David Iain Broadhurst, Akul Singhania, Daniel Horowitz, Ratko Djukanović, Timothy S.C. Hinks, Paul Geladi, Johan Trygg, et al.

    Integration of multi-omics data remains a key challenge in fulfilling the potential of comprehensive systems biology. Multiple-block orthogonal projections to latent structures (OnPLS) is a projection method that simultaneously models multiple data matrices, reducing feature space without relying on a priori biological knowledge. In order to improve the interpretability of OnPLS models, the associated multi-block variable influence on orthogonal projections (MB-VIOP) method is used to identify variables with the highest contribution to the model. This study combined OnPLS and MB-VIOP with interactive visualisation methods to interrogate an exemplar multi-omics study, using a subset of 22 individuals from an asthma cohort. Joint data structure in six data blocks was assessed: transcriptomics; metabolomics; targeted assays for sphingolipids, oxylipins, and fatty acids; and a clinical block including lung function, immune cell differentials, and cytokines. The model identified 7 components, 2 of which had contributions from all blocks (globally joint structure), and 5 that had contributions from 2-5 blocks (locally joint structure). Components 1 and 2 were the most informative, identifying differences between healthy controls and asthmatics, and a disease-sex interaction, respectively. The interactions between features selected by MB-VIOP were visualised using chord plots, yielding putative novel insights into asthma disease pathogenesis, the effects of asthma treatment, and biological roles of uncharacterised genes. For example, the gene ATP6V1G1, which has been implicated in osteoporosis, correlated with metabolites that are dysregulated by inhaled corticoid steroids (ICS), providing insight into the mechanisms underlying bone density loss in asthma patients taking ICS. These results show the potential for OnPLS, combined with MB-VIOP variable selection and interaction visualisation techniques, to generate hypotheses from multi-omics studies and inform biology.


  • The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis

    by Akul Singhania, Robert J. Wilkinson, Marc Rodrigue, Pranabashis Haldar, Anne O’gArra

    Blood transcriptomics analysis of tuberculosis has revealed an interferon-inducible gene signature that diminishes in expression after successful treatment; this promises improved diagnostics and treatment monitoring, which are essential for the eradication of tuberculosis. Sensitive radiography revealing lung abnormalities and blood transcriptomics have demonstrated heterogeneity in patients with active tuberculosis and exposed asymptomatic people with latent tuberculosis, suggestive of a continuum of infection and immune states. Here we describe the immune response to infection with Mycobacterium tuberculosis revealed through the use of transcriptomics, as well as differences among clinical phenotypes of infection that might provide information on temporal changes in host immunity associated with evolving infection. We also review the diverse blood transcriptional signatures, composed of small sets of genes, that have been proposed for the diagnosis of tuberculosis and the identification of at-risk asymptomatic people and suggest novel approaches for the development of such biomarkers for clinical use.